PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 434,000
+31,000 (7.69%)
At close: Jan 2, 2026
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 4.19 trillion as of January 2, 2026. Its market cap has increased by 88.76% in one year.
Market Cap
4.19T
Enterprise Value
3.89T
Revenue
496.03B
Ranking
n/a
PE Ratio
27.75
Stock Price
434,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 4.19T, an increase of 314.86%. That is a compound annual growth rate of 14.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.46T |
| Celltrion | 39.60T |
| ALTEOGEN | 24.04T |
| ABL Bio | 11.03T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.39T |
| HLB Co., Ltd. | 6.69T |
| LigaChem Biosciences | 6.32T |